Previous work has demonstrated that upregulation of miR-503 leads to inhibition of tumor angiogenesis through regulation of FGF2 and VEGFA39, while downregulation of miR-503 in ECs has been suggested to lead to improved angiogenesis in diabetes mellitus40. This evidence concerns the gene FGF2 and neoplasm.